Table 2.
Surgical procedures and outcomes of participants with or without conbercept pretreatment.
Preoperative intravitreal conbercept (n = 54) | Control (n = 53) | P value | |
---|---|---|---|
Severity of intraoperative bleeding grade | 0.002 | ||
3 | 3 | 10 | |
2 | 10 | 22 | |
1 | 27 | 14 | |
0 | 14 | 7 | |
Recurrent VH | |||
≤4 weeks | 9 (16.67%) | 26 (49.05%) | 0.000 |
Severity of recurrent VH grade | 0.000 | ||
4 | 0 | 1 | |
3 | 0 | 2 | |
2 | 2 | 8 | |
1 | 7 | 15 | |
>4 weeks | 6 (11.11%) | 8 (15.01%) | 0.973 |
Severity of recurrent VH grade | 0.732 | ||
4 | 0 | 0 | |
3 | 0 | 1 | |
2 | 2 | 3 | |
1 | 4 | 4 |
VH: vitreous hemorrhage.